Inventor · disambiguated record
Aijun Lu
Also filed as: LU AIJUN
10 granted patents·3 pending applications·13 citations·filing 2016–2023
81Inventor score
Top patents by PatentIndex Score
13 records- 0190US10407424B2Naphthyridines as inhibitors of HPK1GENENTECH INC·Filed 2018·Granted Sep 10, 2019·5 cites·72 claims
- 0284US10179782B2Substituted sulfonamide compoundsGENENTECH INC·Filed 2016·Granted Jan 15, 2019·5 cites·10 claims
- 0381US11034692B1Naphthyridines as inhibitors of HPK1GENENTECH INC·Filed 2019·Granted Jun 15, 2021·1 cites·20 claims
- 0475US12187742B2Dual ATM and DNA-PK inhibitors for use in anti-tumor therapyXRAD THERAPEUTICS INC·Filed 2020·Granted Jan 7, 2025·1 cites·25 claims
- 0570US10065970B2Tricyclic PI3K inhibitor compounds and methods of useGENENTECH INC·Filed 2016·Granted Sep 4, 2018·1 cites·18 claims
- 0653US2024383915A1Oxazepine compounds and uses thereof in the treatment of cancerGENENTECH INC·Filed 2022·Application pending·0 cites
- 0752US10913742B2Oxadiazolones as transient receptor potential channel inhibitorsGENENTECH INC·Filed 2019·Granted Feb 9, 2021·0 cites·13 claims
- 0851US11760744B2Fused ring compoundsGENENTECH INC·Filed 2019·Granted Sep 19, 2023·0 cites·28 claims
- 0950US10435414B2Tricyclic PI3K inhibitor compounds and methods of useGENENTECH INC·Filed 2018·Granted Oct 8, 2019·0 cites·23 claims
- 1049US2022142995A1Dual atm and dna-pk inhibitors for use in anti-tumor therapyXRAD THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1148US10711004B2Oxadiazole transient receptor potential channel inhibitorsGENENTECH INC·Filed 2019·Granted Jul 14, 2020·0 cites·23 claims
- 1248US2025230129A1Polyamide compounds, method for preparing same, and medical use thereofJIANGSU NHWA PHARMACEUTICAL CO LTD·Filed 2023·Application pending·0 cites
- 1343US10280165B2Pyridopyrimidinones and methods of use thereofGENENTECH INC·Filed 2017·Granted May 7, 2019·0 cites·28 claims
Join the waitlist — get patent alerts
Get an alert when Aijun Lu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →